Sophie Wedekind

• Science & Technology
• Health & Medicine

NICE recommends elranatamab for adults with a rare form of blood cancer

The National Institute for Health and Care Excellence (NICE) has recommended the use of elranatamab for adults with multiple myeloma, a cancer that forms in a type of white blood cell called a plasma cell. The National Institute for Health and Care Excellence (NICE) has recommended the use of elranatamab for adults with multiple myeloma, a cancer that forms in a type of white blood cell called a plasma cell.

1 November 2024

• Science & Technology
• Charity News

£3m for world-first trial to revolutionise brain cancer treatment

A pioneering UK-wide trial, the 5G trial, has been awarded over £3m, by Cancer Research UK and the Minderoo Foundation, to test new treatments for people living with brain cancer.   A pioneering UK-wide trial, the 5G trial, has been awarded over £3m, by Cancer Research UK and the Minderoo Foundation, to test new treatments for people living with brain cancer.  

23 October 2024

• Science & Technology

Selenium: Could a common mineral help prevent the spread of cancer?

Limiting breast cancer cells’ ability to consume selenium, an essential mineral found in Brazil nuts, could be a way to stop them spreading. Limiting breast cancer cells’ ability to consume selenium, an essential mineral found in Brazil nuts, could be a way to stop them spreading.

22 October 2024

• Science & Technology

New hand-held scanner could transform cancer and arthritis diagnosis

A new scanner, that has been developed by University College London (UCL) researchers, is able to generate highly detailed 3D images in seconds. Using this technology could offer the potential for earlier disease diagnosis in a clinical setting for the first time. A new scanner, that has been developed by University College London (UCL) researchers, is able to generate highly detailed 3D images in seconds. Using this technology could offer the potential for earlier disease diagnosis in a clinical setting for the first time.

15 October 2024

• Health & Medicine

Cervical cancer treatment breakthrough cuts risk of death by 40%

Researchers funded by Cancer Research UK have made the biggest improvement in cervical cancer treatment in more than 20 years by changing how we use existing drugs.  Researchers funded by Cancer Research UK have made the biggest improvement in cervical cancer treatment in more than 20 years by changing how we use existing drugs. 

14 October 2024

• Charity News

£600,000 given to create the world’s first ovarian cancer prevention vaccine

Researchers at the University of Oxford have been awarded up to £600,000 from Cancer Research UK to create the world’s first vaccine to prevent ovarian cancer. Researchers at the University of Oxford have been awarded up to £600,000 from Cancer Research UK to create the world’s first vaccine to prevent ovarian cancer.

4 October 2024

• Health & Medicine

More than 900,000 cancer deaths predicted in the next 5 years

Our latest analysis suggests there could be more than 900,000 cancer deaths in the UK by the end of the new government’s first parliamentary term if we don't take bold action. Our latest analysis suggests there could be more than 900,000 cancer deaths in the UK by the end of the new government’s first parliamentary term if we don't take bold action.

9 September 2024

• Science & Technology
• Charity News

£27m being invested to transform treatment for children with cancer

Cancer Research UK and LifeArc are investing £27m in funding and resources as part of a pioneering international initiative dedicated to developing new medicines exclusively for children’s and young people’s cancers. Cancer Research UK and LifeArc are investing £27m in funding and resources as part of a pioneering international initiative dedicated to developing new medicines exclusively for children’s and young people’s cancers.

5 September 2024

• Health & Medicine

NICE recommends pembrolizumab for advanced stomach cancers

The immunotherapy drug pembrolizumab (also known as Keytruda) has been approved as an option for people with advanced gastric cancer. The immunotherapy drug pembrolizumab (also known as Keytruda) has been approved as an option for people with advanced gastric cancer.

7 August 2024

• Health & Medicine
• Policy & Insight

34,000 cancer deaths could be prevented if we make this election a turning point for cancer

The UK could avoid 34,000 cancer deaths within a decade of the general election on 4 July if the next government takes urgent action to improve cancer outcomes. The UK could avoid 34,000 cancer deaths within a decade of the general election on 4 July if the next government takes urgent action to improve cancer outcomes.

6 June 2024

• Health & Medicine

Are ultra-processed foods linked to cancer?

The term ‘ultra-processed foods’ has been hard to avoid in recent years. But what are they? And do they really impact our health? The term ‘ultra-processed foods’ has been hard to avoid in recent years. But what are they? And do they really impact our health?

18 April 2024

• Charity News

£58.7 million to train the next generation of clinician scientists

Cancer Research UK announces universities across Scotland and England will receive a multimillion-pound cash injection to train more doctors as clinician scientists. Cancer Research UK announces universities across Scotland and England will receive a multimillion-pound cash injection to train more doctors as clinician scientists.

5 April 2024